Hull University Teaching Hospitals NHS Trust is delighted to welcome Prof Adele Fielding to Queen’s Centre for Oncology and Haematology at Castle Hill Hospital, Cottingham.
Prof Fielding, renowned professor of haematology will be seeing patients at the Queen’s Centre as part of her role as Clinical Director of the University of York’s newly opened Centre for Blood Research.
Although her main work will be at the Centre and the Hull York Medical School (HYMS) where she serves as Head of Experimental Biomedicine, Prof Fielding will be seeing cancer patients at the Queen’s Centre once a week.
With a remarkable career spanning over three decades, Prof Fielding brings a wealth of expertise in blood cancer research to the Queen’s Centre where she will be carrying out clinical trials. The Queen’s Centre is a state-of-the-art facility primarily dedicated to serving cancer patients across the Yorkshire region. It also houses essential services such as immunology and allergy, haemophilia and lymphoedema.
Prior to her move to Hull, she held a prominent role at the University College London Cancer Institute, specialising in the research and treatment of acute lymphoblastic leukaemia (ALL).
Commenting on the move, Prof Fielding said:
”I had a choice about where to do my clinical work and I selected Hull because I think it is important that people realise there are really good haematology departments that aren’t just based in London or Oxford or Cambridge. I know that the department at the Queen’s Centre is staffed with excellent people who are absolutely brilliant.
“They have succeeded in recruiting a lot of patients into national trials and are a really cooperative unit, nationally. They experience different clinical and service issues to some of those I’ve faced in my previous clinical career and I thought it would be important for me to see some of those issues for myself and see if I can help.
“I am not going to help by seeing a million patients, but I might be able to help by working with my colleagues to get them the recognition that they deserve on the national stage and also let people know that Hull is a great place to work.”
Prof Fielding’s work on ALL is vast. Her research has looked into improving the lives of people living with the rare disease which affects both children and adults. She has led several clinical trials into ALL, which include studying the underlying mechanisms and searching for new treatments.
The Queen’s Centre is confident that Prof Fielding’s wealth of experience and expertise will contribute significantly its cancer work.
James Bailey, Medical Director, Clinical Support Health Group said: “The Queen’s Centre haematology team are delighted to have Prof Fielding working with us. Her incredible experience in cutting-edge leukaemia research and practical clinical management is already bringing real benefit to our patients being treated at the Queen’s Centre.
“We anticipate seeing a growth in our clinical activity enabling us to offer exciting new opportunities for patients receiving treatment across our region whilst helping to further develop Queen’s Centre as an exciting place for staff to come and work.”
Professor Matthew Morgan, Dean of Hull York Medical School said: “Research is a fundamental part of medicine, ensuring that approaches to diagnosis, treatment and care focus on those things which really matter to patients. We are delighted that Adele is joining our community of clinical academic researchers at Hull University Teaching Hospitals NHS Trust and know that, together with her colleagues, she will make a real and lasting difference to the lives of cancer patients in our region.”